ArticleInternational journal of hematology2014

Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study.

Michele Baccarani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.